Protective effect of the APOE-e3 allele in Alzheimer's disease

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 1, 2012, Pages 8-12

  de Almada, B V P ^a   de Almeida, L D ^a   Camporez, D ^a   de Moraes, M V D ^a   Morelato, R L ^b   Perrone, A M S ^a   Belcavello, L ^a   Louro, I D ^a   de Paula, F ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

Alzheimer's disease; APOE e3 allele; APOE e4 allele; Brazilian population; Case control study

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAZIL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 84855876435     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500151     Document Type: Article

References (40)

1. Kachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42: 97-105.
2. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002; 59: 1034-1041.
3. Hui JS, Wilson RS, Bennett DA, Bienias JL, Gilley DW, Evans DA. Rate of cognitive decline and mortality in Alzheimer's disease. Neurology 2003; 61: 1356-1361.
4. Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008; 70: 1842-1849.
5. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088-1093.
6. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094-1099.
7. Avramopoulos D. Genetics of Alzheimer's disease: recent advances. Genome Med 2009; 1: 34.
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
9. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, et al. Dose-dependent association of apolipoprotein E allele epsilon 4 with lateonset, sporadic Alzheimer's disease. Ann Neurol 1994; 36: 656-659.
10. Bosco P, Gueant-Rodriguez RM, Anello G, Spada RS, Romano A, Caraci F, et al. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Neurosci Lett 2005; 388: 168-172.
11. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996; 47: 387-400.
12. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7: 180-184.
13. Panza F, Solfrizzi V, Torres F, Mastroianni F, Colacicco AM, Basile AM, et al. Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early-and late-onset sporadic Alzheimer's disease. Neurosci Lett 2000; 292: 79-82.
14. de Andrade FM, Coimbra CE Jr, Santos RV, Goicoechea A, Carnese FR, Salzano FM, et al. High heterogeneity of apolipoprotein E gene frequencies in South American Indians. Ann Hum Biol 2000; 27: 29-34.
15. Oliveira JR, Lima Filho JL, Shimokomaki CM, Okuma M, Passos-Bueno MR, Zatz M, et al. The use of apolipoprotein E genotype for preclinical detection of risk's group for Alzheimer's disease. Am J Med Genet 1997; 74: 216-217.
16. Nishimura AL, Oliveira JR, Mitne-Neto M, Guindalini C, Nitrini R, Bahia VS, et al. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients. J Mol Neurosci 2004; 22: 257-260.
17. Oliveira JR, Nishimura AL, Lemos RR, Zatz M. The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population. J Mol Neurosci 2009; 37: 74-79.
18. Bahia VS, Kok F, Marie SN, Shinjo SO, Caramelli P, Nitrini R. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease. Alzheimer Dis Assoc Disord 2008; 22: 61-65.
19. Souza DR, de Godoy MR, Hotta J, Tajara EH, Brandao AC, Pinheiro JS, et al. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians. Braz J Med Biol Res 2003; 36: 919-923.
20. de Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz J Med Biol Res 2000; 33: 529-537.
21. Fernandez LL, Scheibe RM. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE? Arq Neuropsiquiatr 2005; 63: 1-6.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
24. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
26. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
27. Motulsky HJ. GraphPad InStat. Version 3.06. [Computer program]. California: GraphPad Software, Inc.; 2004.
28. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatr 2011; 16: 903-907.
29. Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, et al. Apolipoprotein E epsilon4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis. Dement Geriatr Cogn Disord 2011; 31: 20-30.
30. Nishimura AL, Guindalini C, Oliveira JR, Nitrini R, Bahia VS, de Brito-Marques PR, et al. Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease? J Mol Neurosci 2005; 27: 213-217.
31. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338-349.
32. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992; 9: 155-167.
33. Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, Shojaee A, et al. Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep 2008; 35: 495-499.
34. Lucotte G, Loirat F, Hazout S. Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 1997; 69: 253-262.
35. Sandholzer C, Delport R, Vermaak H, Utermann G. High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Hum Genet 1995; 95: 46-48.
36. Demarchi DA, Salzano FM, Altuna ME, Fiegenbaum M, Hill K, Hurtado AM, et al. APOE polymorphism distribution among Native Americans and related populations. Ann Hum Biol 2005; 32: 351-365.
37. Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH, Lima-Costa MF. Apolipoprotein E polymorphism distribution in an elderly Brazilian population: the Bambui Health and Aging Study. Braz J Med Biol Res 2007; 40: 1429-1434.
38. Rassas AA, Khiari HM, Fredj SH, Sahnoun S, Batti H, Zakraoui NO, et al. High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population. Neurol Sci 2011; doi: 10.1007/s10072-011-0663-8.
39. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994; 175: 46-48.
40. Thomas P, Fenech M. A review of genome mutation and Alzheimer's disease. Mutagenesis 2007; 22: 15-33.